October 13th 2025
Medical Economics wants to hear from doctors about what patients are asking about in the examination room.
October 10th 2025
A KFF survey shows 77% of U.S. adults heard President Trump’s claim linking Tylenol use in pregnancy to autism. Most don’t believe it.
September 23rd 2025
RFK Jr. targets surge in autism diagnoses with treatment, research projects.
September 22nd 2025
Advisory Committee on Immunization Practices sparks comments from pro-vaxxers.
September 19th 2025
Committee supports improving the testing levels for all pregnant women; physicians question ACIP’s analysis methods.
Liability is limited in vaccine-related injuries
Vaccine-related injuries in adults are rising, but healthcare providers administering those vaccines rarely have to worry about liability claims.
Flu “patch” as effective as shots, preferred by patients
Researchers have developed a microneedle patch that could replace injections for influenza vaccination and a host of other diseases.
Researchers: Pneumonia vaccine could use improvement
U.K. researchers say more research and funding is needed for a more successful alternative to prevent pneumonia infection.
Adults know needed vaccines, but skip them anyway
A new report says the key to increasing adult vaccine compliance may lie in a simple suggestion from a physician.
CDC recommends cholera vaccine for certain U.S. travelers
The federal agency supports a vaccine fast-tracked by the FDA for adults traveling to one of the more than 50 countries where cholera is endemic.
Cost, perception remain barriers in pharmacy-based vaccination
Pharmacies can help reach populations that have difficulty in using traditional channels for vaccines, but obstacles remain.
California team working to develop acne vaccine
A vaccine targeting the protein that contributes to acne breakouts is in development at the University of California, San Diego.
Patients, physicians forgo adult vaccines over cost and coverage concerns
Patients often go without vaccines due to cost, and physicians don’t always recommend them over concerns about reimbursement, according to a new study.
Early viral infection may contribute to celiac development
Researchers believe a vaccine could be developed to prevent the formation of celiac disease and possibly other autoimmune disorders.
Patient prompts can increase flu shot rates nearly 40%
A simple prompt reminding patients of their flu shot was found to be highly effective in a trial run at the University of Pennsylvania.
Researchers target potent HIV antibodies in new study
The newly discovered antibodies can fight nearly every strain of HIV in existence, according to study authors.
Physician groups brace for vaccine questions amid Trump presidency
Between public skepticism on vaccinations and provisions of the American Health Care Act, some representing physicians are voicing concern.
Study: Safety, components concerns spur vaccine hesitancy
Researchers find callers to a national health center were most concerned about the safety and components of vaccines based largely on old information.
Researchers isolate cells that weaken immune response to cancer
Study provides new insight on isolating and suppressing immune cells that could play a vital role in inhibiting other immunotherapy efforts against cancer.
As Arkansas outbreak ends, third MMR dose debate renewed
The prevalence of mumps in the state is reinvigorating the question about whether a third dose of measles, mumps and rubella vaccination is warranted.
Study: Saliva test shows promise in checking immunity status
Saliva-based testing may be just as effective as serum in assessing antibodies against infections like community-acquired pneumonia, according to a new UK study.
Duke launches campaign to boost adult vaccination
Researchers and physicians are working together to discover why adults skip recommended vaccines and what doctors can do to increase immunization rates.
Unvaccinated adults cost U.S. billions in care, lost productivity
Lead researcher hopes results of new study motivates more adults to improve vaccination compliance.
Alzheimer’s vaccine targets early and later disease stages
A new vaccine against Alzheimer’s targets two proteins involved in the development of the disease in hopes to offer both early and late protection.
Researchers zero in on a cure for the common cold
Scientists at Emory University have developed a vaccine they say may work well in preventing infection with rhinovirus-the top cause of the common cold.
Coding, careful planning can reduce vaccine-associated losses
Practices that scrutinize vaccine costs and plan ahead may not make much off of vaccinations, but could cut some of their losses.
CDC announces 2016-17 flu vaccine changes
The CDC reaffirms its decision to pull the intranasal vaccine, but allow vaccination in egg-allergic individuals.
Study: All celiac patients should get pneumococcal vaccine
More susceptible to community-acquired pneumonia, researchers advise those with celiac disease to get vaccinated.
NIH closes in on development of a universal flu vaccine
New research confirms that humans can make antibodies to neutralize several strains of influenza A, according to new study.
7 strategies to maintain a successful vaccine program
A practice’s immunization program requires constant attention and oversight. Here are seven best practices to consider.
Top 5 tips to improve your practice's vaccine process
Keep patients-and your practice’s bottom line-healthy with these suggestions for a successful immunization program.
How to improve your practice's vaccine procurement process
Learn from one practice’s innovative approach to successful vaccine management to improve patient care.
Researchers advance tests of ‘promising’ chlamydia vaccine
A Canadian team is moving forward in advanced animal trials to test what could be the first successful vaccine against chlamydia.
New pneumococcal vaccine may fight all strains of disease
Traditional pneumococcal vaccines can fight up to 23 of the most dangerous strains of pneumococcus, but a new vaccine may be able to fight all 90 strains.
Research team moves toward clinical trials of HIV vaccine
Scientists at Oregon Health & Science University have found a way to reprogram immune cells to recognize and attack early HIV infection.